Data sets containing the data from a population study of non-alcoholic fatty liver disease (NAFLD). Subjects with the condition and a set of matched control subjects were followed forward for metabolic conditions, cardiac endpoints, and death.
1 2 3 4
nafld1 is a data frame with 17549 observations on the following 10 variables.
age at entry to the study
weight in kg
height in cm
body mass index
the id of the NAFLD case to whom this subject is matched
time to death or last follow-up
0= alive at last follow-up, 1=dead
nafld2 is a data frame with 400123 observations and 4 variables
containing laboratory data
days since index date
the type of value recorded
the numeric value
nafld3 is a data frame with 34340 observations and 3 variables
days since index date
the endpoint that occurred
The primary reference for the NAFLD study is Allen (2018). The incidence of non-alcoholic fatty liver disease (NAFLD) has been rising rapidly in the last decade and it is now one of the main drivers of hepatology practice Tapper2018. It is essentially the presence of excess fat in the liver, and parallels the ongoing obesity epidemic. Approximately 20-25% of NAFLD patients will develop the inflammatory state of non-alcoholic steatohepatitis (NASH), leading to fibrosis and eventual end-stage liver disease. NAFLD can be accurately diagnosed by MRI methods, but NASH diagnosis currently requires a biopsy.
The current study constructed a population cohort of all adult NAFLD subjects from 1997 to 2014 along with 4 potential controls for each case. To protect patient confidentiality all time intervals are in days since the index date; none of the dates from the original data were retained. Subject age is their integer age at the index date, and the subject identifier is an arbitrary integer. As a final protection, we include only a 90% random sample of the data. As a consequence analyses results will not exactly match the original paper.
There are 3 data sets:
nafld1 contains baseline data and has
one observation per subject,
nafld2 has one observation for
each (time dependent) continuous measurement,
nafld3 has one observation for
each yes/no outcome that occured.
Data obtained from the author.
AM Allen, TM Therneau, JJ Larson, A Coward, VK Somers and PS Kamath, Nonalcoholic Fatty Liver Disease Incidence and Impact on Metabolic Burden and Death: A 20 Year Community Study, Hepatology 67:1726-1736, 2018.
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.